Literature DB >> 21958118

Promiscuity of carbonic anhydrase II. Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors.

Marie Lopez1, Hoan Vu, Conan K Wang, Maarten G Wolf, Gerrit Groenhof, Alessio Innocenti, Claudiu T Supuran, Sally-Ann Poulsen.   

Abstract

Carbonic anhydrases (CAs) are enzymes whose endogenous reaction is the reversible hydration of CO(2) to give HCO(3)(-) and a proton. CA are also known to exhibit weak and promiscuous esterase activity toward activated esters. Here, we report a series of findings obtained with a set of CA inhibitors that showed quite unexpectedly that the compounds were both inhibitors of CO(2) hydration and substrates for the esterase activity of CA. The compounds comprised a monosaccharide core with the C-6 primary hydroxyl group derivatized as a sulfamate (for CA recognition). The remaining four sugar hydroxyl groups were acylated. Using protein X-ray crystallography, the crystal structures of human CA II in complex with four of the sulfamate inhibitors were obtained. As expected, the four structures displayed the canonical CA protein-sulfamate interactions. Unexpectedly, a free hydroxyl group was observed at the anomeric center (C-1) rather than the parent C-1 acyl group. In addition, this hydroxyl group is observed axial to the carbohydrate ring while in the parent structure it is equatorial. A mechanism is proposed that accounts for this inversion of stereochemistry. For three of the inhibitors, the acyl groups at C-2 or at C-2 and C-3 were also absent with hydroxyl groups observed in their place and retention of stereochemistry. With the use of electrospray ionization-Fourier transform ion cyclotron resonance-mass spectrometry (ESI-FTICR-MS), we observed directly the sequential loss of all four acyl groups from one of the carbohydrate-based sulfamates. For this compound, the inhibitor and substrate binding mode were further analyzed using free energy calculations. These calculations suggested that the parent compound binds almost exclusively as a substrate. To conclude, we have demonstrated that acylated carbohydrate-based sulfamates are simultaneously inhibitor and substrate of human CA II. Our results suggest that, initially, the substrate binding mode dominates, but following hydrolysis, the ligand can also bind as a pure inhibitor thereby competing with the substrate binding mode.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21958118     DOI: 10.1021/ja207855c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  6 in total

1.  α,γ-Diketocarboxylic Acids and Their Esters Act as Carbonic Anhydrase IX and XII Selective Inhibitors.

Authors:  Alessio Nocentini; Alessia Lucidi; Francesca Perut; Annamaria Massa; Daniela Tomaselli; Paola Gratteri; Nicola Baldini; Dante Rotili; Antonello Mai; Claudiu T Supuran
Journal:  ACS Med Chem Lett       Date:  2019-02-19       Impact factor: 4.345

2.  Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates.

Authors:  Janina Moeker; Brian P Mahon; Laurent F Bornaghi; Daniela Vullo; Claudiu T Supuran; Robert McKenna; Sally-Ann Poulsen
Journal:  J Med Chem       Date:  2014-10-08       Impact factor: 7.446

3.  Mechanistic Explanation of the Weak Carbonic Anhydrase's Esterase Activity.

Authors:  Paolo Piazzetta; Tiziana Marino; Nino Russo
Journal:  Molecules       Date:  2017-06-18       Impact factor: 4.411

4.  Investigation of pesticides on honey bee carbonic anhydrase inhibition.

Authors:  Ercan Soydan; Ahmet Can Olcay; Gürkan Bilir; Ömer Taş; Murat Şentürk; Deniz Ekinci; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

5.  Nitrous anhydrase activity of carbonic anhydrase II: cysteine is required for nitric oxide (NO) dependent phosphorylation of VASP in human platelets.

Authors:  Dimitrios Tsikas; Stepan Gambaryan
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  An overview of carbohydrate-based carbonic anhydrase inhibitors.

Authors:  Doretta Cuffaro; Elisa Nuti; Armando Rossello
Journal:  J Enzyme Inhib Med Chem       Date:  2020-10-20       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.